Joint investment with UU Invest and SLU Holding in new cancer therapy
LiU Invest invests together with UU Invest in MyCural Therapeutics AB. The team includes researchers with connections to Uppsala University, Linköping University and Karolinska Institutet.
MyCural Therapeutics develops drug candidates for cancer treatment. The goal is to develop new treatments for patients with aggressive, resistant, metastatic high-risk tumors.
The investment is made together with UU Invest.
- Being able to collaborate with our colleagues in Uppsala who have extensive experience in life science is a great advantage for us, says Jonas Nilsson, Investment Manager, LiU Invest
In connection with this investment, private investors also come in and the company takes in a total of about SEK 3 million.